ACTN2 p.Ala259Val
c.776C>T · rs566552494 · VCV463217
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5642 | likely pathogenic |
|---|---|---|
| REVEL | 0.593 | indeterminate |
| SaProt | LLR -11.26 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2.4, phastCons 1 |
| Regional constraint | o/e 0.65 | unconstrained · MANE · 50 kb · p 1.6e-10 · regional, not allelic |
| Overall | ||
| CADD | 28.7 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0165% | 6,062 |
| European (non-Finnish) | 0.00186% | 53,636 |
| African / African-American | 0.00133% | 75,044 |
| South Asian | 0.0011% | 91,086 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ACTN2
- Protein
- p.Ala259Val
- Coding
- c.776C>T
- MANE Select
- NM_001103
- dbSNP
- rs566552494
- Type
- single nucleotide variant
- Location
- chr1:236735713 (GRCh38)
- Gene constraint
- LOEUF 0.432 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 84.88 · 18 PDB
Disease context
dilated cardiomyopathy 1AA — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: familial hypertrophic cardiomyopathymyopathy, congenital, with structured cores and z-line abnormalitiesmyopathy, distal, 6, adult-onset, autosomal dominant
Similar variants
- ACTN2 p.Ala259Thr Uncertain significance ★★ ⚠ same residue
- ACTN2 p.Ala259= Conflicting classifications of pathogenicity ★ same residue
- ACTN2 p.Ala119Thr Pathogenic/Likely pathogenic ★★ same condition
- ACTN2 p.Leu727Arg Pathogenic/Likely pathogenic ★★ same condition
- ACTN2 p.Thr247Met Likely pathogenic ★★ same condition
- ACTN2 c.1107+3G>A Uncertain significance ★★ same condition
- ACTN2 c.1108-10A>G Uncertain significance ★★ same condition
- ACTN2 c.1255+1G>C Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/actn2-p-ala259val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown